Search for: "Epstein Becker Green" Results 221 - 240 of 1,495
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2023, 8:40 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA’s latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply with, that guidance [read post]
2 Feb 2023, 8:53 am by Epstein Becker Green
Wendy and Epstein Becker Green attorneys Lynn Shapiro Snyder, Kevin Malone, and Helaine Fingold explore the ins and outs of PACE, the changes in recent years that have made PACE available to for-profit companies, and the specifics of the provisions in the pending federal proposed rule [read post]
30 Jan 2023, 7:40 am by Amy K. Dow
The state laws at issue require that Mifepristone be taken in the presence of a physician, who must first provide state-mandated counseling to the patient before waiting 72 hours before administering the medication.[9] For additional resources on these topics, please see Epstein Becker Green’s From Roe to Dobbs additional resources [read post]
26 Jan 2023, 8:26 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Kate Heffernan, Marylana Helou, and Megan Robertson discuss how the changing state laws and regulations post-Dobbs may impact clinical research in different ways for different stakeholders [read post]
12 Jan 2023, 8:50 am by Epstein Becker Green
Epstein Becker Green attorneys Ted Kennedy, Jr.; Alexis Boaz; and Philo Hall discuss the current landscape of health care policy from both the legislative and regulatory perspectives and analyze which key health care issues may arise [read post]
10 Jan 2023, 8:39 am by Alaap B. Shah
Epstein Becker Green will be closely following the rulemaking process in these states as implementing regulations are developed, and as other states continue to legislate in this area. [read post]
23 Dec 2022, 11:29 am by Adam S. Forman and Nathaniel M. Glasser
Epstein, Becker & Green, P.C. will continue to monitor and publish updates on this topic. [read post]
1 Dec 2022, 8:49 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements [read post]
17 Nov 2022, 8:24 am by Epstein Becker Green
Brett and Epstein Becker Green construction attorney Chris Dunn analyze recent national trends in construction claims and discuss what health care owners can expect moving forward. [read post]
15 Nov 2022, 7:30 am by Amy Lerman
Since 2016, Epstein Becker Green has researched, compiled, and analyzed state-specific content relating to the regulatory requirements for professional mental/behavioral health practitioners and stakeholders seeking to provide telehealth-focused services. [read post]
3 Nov 2022, 8:50 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Jenny Nelson Carney, Stuart Gerson, Erin Sutton, and Dan Fahey discuss the post-Dobbs legislative landscape as well as the ongoing enforcement actions in the states that prohibit all or most abortions and abortion-related services. [read post]
2 Nov 2022, 1:39 pm by Shannon K. DeBra
For an additional summary of details regarding REHs, see the CMS Fact Sheet published on November 1, 2022 or for questions contact your Epstein Becker & Green, P.C. attorney. [read post]